Affiliation:
1. T.J. Montine and K.S. Montine are at the Department of Pathology, University of Washington, Seattle, WA 98104
Abstract
The goal of precision medicine is to deliver optimally targeted and timed interventions tailored to an individual’s molecular drivers of disease. This concept has wide currency in cancer care and in some diseases caused by monogenetic mutations, such as cystic fibrosis, and recently has been endorsed by the White House Office of Science and Technology for more widespread application in medicine. Here we describe our vision of how precision medicine can bring greater clarity to the clinical and biological complexity of the two most common neurodegenerative diseases, Alzheimer’s disease and Parkinson’s disease.
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Reference50 articles.
1. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study;Aarsland;Arch. Neurol.,2003
2. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement.,2011
3. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study;Alcalay;Neurology.,2012
4. Alzheimer’s Association and Centers for Disease Control and Prevention. 2013. The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013–2018. Alzheimer’s Association, Chicago, IL. Available at: http://www.alz.org/publichealth/downloads/2013-RoadMap.pdf (accessed April 15, 2015).
5. Submandibular gland biopsy for the diagnosis of Parkinson disease;Beach;J. Neuropathol. Exp. Neurol.,2013
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献